---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-234440"
form_type: "8-K"
ticker: "TMDX"
cik: "0001756262"
company_name: "TransMedics Group, Inc."
filed_at: "2026-05-21T20:15:24+00:00"
generated_at: "2026-05-21T22:06:04.513537+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# TransMedics shareholders approve director elections, equity plan amendment increasing share reserve to 5.39M shares

## Summary
- All eight director nominees elected; advisory say-on-pay approved with 22.9M for, 1.16M against.
- Amendment to 2019 Stock Incentive Plan approved: share reserve increased to 5,390,502 shares (includes 2,640,502 outstanding awards).
- Plan term extended to June 1, 2036; new grants on/after Jan 1, 2027 subject to minimum one-year vesting (5% carve-out).
- PricewaterhouseCoopers ratified as independent auditor for FY 2026 with 28.0M votes for.

## SEC filing metadata
- accession: 0001193125-26-234440
- form_type: 8-K
- ticker: TMDX
- cik: 0001756262
- company_name: TransMedics Group, Inc.
- filed_at: 2026-05-21T20:15:24+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1756262/000119312526234440/0001193125-26-234440-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1756262/000119312526234440/d79022d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-234440
- JSON: https://secwatch.observer/filing/0001193125-26-234440.json
- Plain text: https://secwatch.observer/filing/0001193125-26-234440.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.